Cancer

Chronic Lymphocytic

Leukemia, especially chronic lymphocytic leukemia (CLL) in remission, can be favorably considered. Acute myelogenous leukemia (AML), however, is less likely to result in certification, although childhood AML that was successfully treated many years prior may also be considered favorably.

For special issuance consideration, the FAA will require the following:

• All pertinent medical records (i.e. hospital records, diagnostic testing, laboratory blood work reports, treatment records).
• A detailed, current status report from the treating physician to include date of diagnosis, treatment plan, medication information, current condition and prognosis.

AASI for Chronic Lymphocytic Leukemia

After initial certification by the FAA, subsequent renewals may qualify for AME Assisted Special Issuance (AASI), a program that allows aviation medical examiners to reissue an airman medical certificate under a special issuance authorization. The authorization letter will allow the examiner to reissue the medical certificate if the applicant provides:

• An authorization granted by the FAA
• A current status report performed within 90 days that must include all the required follow-up items and studies as listed in the authorization letter and that confirms absence of recurrent disease

The examiner should defer to the AMCD or Region if:

• The condition has progressed to the point that treatment with a chemotherapeutic agent is necessary.
• The white blood cell count has risen above 80,000.

For more information, click here

How/Where to Submit to the FAA

Helps you find the contact information for submitting your medical records.

Updated August 11, 2017